Significant reduction of plasma gelsolin levels in patients with intracerebral hemorrhage

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 202-206

  Zhao, Dong Qing ^a   Wang, Ke ^a   Zhang, Hai Dong ^a   Li, Yu Jian ^a  

^a Zhejiang Xiaoshan Hospital   (China)

Author keywords

Functional outcome; Gelsolin; Intracerebral hemorrhage; Mortality

Indexed keywords

C REACTIVE PROTEIN; D DIMER; GELSOLIN; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTE OF HEALTH STROKE SCALE SCORE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CEREBRAL HEMORRHAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GELSOLIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84869222864     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.048     Document Type: Article

References (33)

1. Kwiatkowski D.J., Mehl R., Izumo S., Nadal-Ginard B., Yin H.L. Muscle is the major source of plasma gelsolin. J Biol Chem 1988, 263:8239-8243.
2. Maeda K., Okubo K., Shimomura I., Mizuno K., Matsuzawa Y., Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997, 190:227-235.
3. Kwiatkowski D.J., Stossel T.P., Orkin S.H., Mole J.E., Colten H.R., Yin H.L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986, 323:455-458.
4. Coue M., Korn E.D. Interaction of plasma gelsolin with ADP-actin. J Biol Chem 1986, 261:3628-3631.
5. Lee W.M., Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992, 326:1335-1341.
6. Christofidou-Solomidou M., Scherpereel A., Solomides C.C., et al. Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 2002, 180:91-104.
7. Dahl B., Schiødt F.V., Ott P., Gvozdenovic R., Yin H.L., Lee W.M. Plasma gelsolin is reduced in trauma patients. Shock 1999, 12:102-104.
8. DiNubile M.J., Stossel T.P., Ljunghusen O.C., Ferrara J.L., Antin J.H. Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood 2002, 100:4367-4371.
9. Huang S., Rhoads S.L., DiNubile M.J. Temporal association between serum gelsolin levels and clinical events in a patient with severe falciparum malaria. Clin Infect Dis 1997, 24:951-954.
10. Ito H., Kambe H., Kimura Y., et al. Depression of plasma gelsolin level during acute liver injury. Gastroenterology 1992, 102:1686-1692.
11. Lee P.S., Drager L.R., Stossel T.P., Moore F.D., Rogers S.O. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006, 243:399-403.
12. Lee P.S., Waxman A.B., Cotich K.L., Chung S.W., Perrella M.A., Stossel T.P. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007, 35:849-855.
13. Mounzer K.C., Moncure M., Smith Y.R., Dinubile M.J. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 1999, 160:1673-1681.
14. Rothenbach P.A., Dahl B., Schwartz J.J., et al. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004, 96:25-31.
15. Suhler E., Lin W., Yin H.L., Lee W.M. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 1997, 25:594-598.
16. Peddada N., Sagar A., Ashish Garg R. Plasma gelsolin: a general prognostic marker of health. Med Hypotheses 2012, 78:203-210.
17. Chou S.H., Lee P.S., Konigsberg R.G., et al. Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke 2011, 42:3624-3627.
18. Guo X.C., Luo B.Y., Li X.F., Yang D.G., Zheng X.N., Zhang K. Plasma gelsolin levels and 1-year mortality after first-ever ischemic stroke. J Crit Care 2011, 26:608-612.
19. Xu J.F., Liu W.G., Dong X.Q., Yang S.B., Fan J. Change in plasma gelsolin level after traumatic brain injury. J Trauma Acute Care Surg 2012, 72:491-496.
20. Kothari R.U., Brott T., Broderick J.P., et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996, 27:1304-1305.
21. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1-5.
22. Bucki R., Levental I., Kulakowska A., Janmey P.A. Plasma gelsolin function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 2008, 9:541-551.
23. Li G.H., Arora P.D., Chen Y., McCulloch C.A., Liu P. Multifunctional roles of gelsolin in health and diseases. Med Res Rev 2012, 32:999-1025.
24. Ashish, Paine M.S., Perryman P.B., Yang L., Yin H.L., Krueger J.K. Global structure changes associated with Ca2+ activation of full-length human plasma gelsolin. J Biol Chem 2007, 282:25884-25892.
25. Garg R., Peddada N., Sagar A., Nihalani D., Ashish Visual insight into how low phalone can induce actin-severing ability in gelsolin under calcium-free conditions. J Biol Chem 2011, 286:20387-20397.
26. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999, 274:33179-33182.
27. Yin H.L., Stull J.T. Proteins that regulate dynamic actin remodeling in response to membrane signaling minireview series. J Biol Chem 1999, 274:32529-32530.
28. Lee W.M., Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992, 326:1335-13341.
29. Bucki R., Kulakowska A., Byfield F.J., et al. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol 2010, 299:C1516-C1523.
30. Lind S.E., Janmey P.A. Human plasma gelsolin binds to fibronectin. J Biol Chem 1984, 259:13262-13266.
31. Osborn T.M., Dahlgren C., Hartwig J.H., Stossel T.P. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007, 292:C1323-C1330.
32. Rothenbach P.A., Dahl B., Schwartz J.J., et al. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004, 96:25-31.
33. Endres M., Fink K., Zhu J., et al. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest 1999, 103:347-354.